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An aromatic 2-chloroethylamino group was attached to the S-terminal phosphate of the oligodeoxyribo- 
nucleotide pCCCTCTTTCTT. The oligonucleotide derivative prepared was used for modification of the 
365-nucleotide-long DNA fragment. It was found that modification of the fragment proceeds in a sequence- 
specific way at 3 guanosine residues within the sequence complementary to the oligonucleotide reagent. 
Nucleic acid Affinity modification 
1. INTRODUCTION 
Complementary addressed modification of nu- 
cleic acids with oligonucleotide derivatives carry- 
ing reactive groups was proposed as an approach 
to sequence-specific derivatization of nucleic acids 
at arbitrary nucleotides [l-3]. The potential use of 
this approach in molecular biology and medicine 
was reviewed in [2-51. Recently it was demon- 
strated that specific arrest of translation of pre- 
selected mRNAs can be achieved by means of the 
complementary addressed modification [6]. Modi- 
fication with alkylating oligonucleotide derivatives 
was investigated with model systems, synthetic 
complementary oligonucleotides [7,8]. An attempt 
to accomplish complementary addressed modifica- 
tion of a 203-nucleotide-long DNA fragment was 
reported in [9]. 
Here we demonstrate the sequence-specific modi- 
fication of a 365-nucleotide-long DNA fragment 
within the preselected region with the complemen- 
tary alkylating oligonucleotide derivative. 
2. MATERIALS AND METHODS 
The undecanucleotide pCCCTCTTTCTT was 
synthesized by the triester method as described in 
[lo]. An alkylating derivative of the oligonucleo- 
tide carrying a 2-chloroethylamino group at its 
5 ’ -terminal phosphate was synthesized according 
to [ 111. The oligonucleotide reagent was purified 
by chromatography on a Lichrosorb 5-Cl8 column 
with an acetonitrile gradient containing 0.2 M 
LiC104 and isolated by precipitation with a IO-fold 
excess of 2% LiC104 solution in acetone. 
The 365-nucleotide-long DNA fragments were 
prepared by RsaI digestion of the plasmid pEMC 
[ 12- 141. Plasmid DNA was isolated as described in 
[15]. Isolation of the DNA fragments and DNA 
strand separation by treatment with 5 mM oxy- 
methylmercury was performed by gel electropho- 
resis in 6% polyacrylamide gel. The fragment was 
labelled at the 3 ’ -end with E.coli DNA polymerase 
and 32P-labelled deoxyribonucleoside triphos- 
phates. Purine-specific splitting of DNA fragments 
by treatment with 2% diphenylamine in 67% for- 
mic acid was described in 1161. 
DNA fragments were alkylated with the oligo- 
nucleotide reagent in 0.15 M NaCl, 20 mM Tris- 
HCl, pH 7.3, 1 mM EDTA. Concentrations of 
DNA fragments in reaction mixtures were -0.1 
A260 units/ml and the oligonucleotide reagent was 
taken in 30-fold molar excess. The reaction was 
terminated by addition of 2pg Ml3 mp9-21 DNA, 
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1: 10 (v/v) 3 M sodium acetate, pH 4.8, and 3 vols 
ethanol. The mixture was chilled to -20°C and the 
DNA precipitate was cotlected by centrif~~~tion_ 
For splitting of modified DNA fragments treat- 
ment was performed with 10% piperidine [17]. 
3. RESULTS AND DISCUSSION A AAAACTTCTACCTTY~~Y~TTAATTCGACGCYTGAAGA~GTYGTC 
Here we have chosen a ~~~-n~~l~~~id~-I~n~ 
single-strapped DNA fragment as a target far com- 
plementary addressed modification. The sequence 
of the fragment represents a sequence in the 3 ’ - 
terminal region of the mouse encephalomyocard~t~s 
RNA, positions 6688.7705 [X3,14]. This fragment 
is a part of a longer 600&p sequence cloned in pias- 
mid pBR 322 at the Psf site [12]. A part of this se- 
quence, fragment Psr 500, was also cloned into bac- 
teriophage Ml3 mp9 at the !Wl site (fig. 1). Hybrid 
phages containing the DNA fragment - analog of 
the viral RNA sequence and the DNA fragment 
complementary to this sequence were constructed 
(clones M 13 mp9-21 and M 13 mp9-22, respective- 
ly). To prepare the single-Waded DNA fragments 
replicative form DNA of the hybrid phages or plas- 
mid pEMC DNA were digested with I&X restric- 
tion endonuclease and the 365bp-Iong fragment 
was isolated by eIectrophores~s~ After 3 ’ -terminal 
labelfing the DNA strands were separated by gel 
eiectrophoresis. Fig. 2 shows the sequence of the 
target DNA fragment. In experiments with s2P- 
Iabelled ohgonucteotide pCCCTCTTTCTT it was 
found that the o~igonucleo~ide binds efficiently to 
the single-stranded DNA of the hybrid phage 1\413 
mp9-21 but nat to that of the phage Ml3 mp9-22. 
Ecoli DNA palymerase 1 elongates the fragment 
bound oli~o~ucleotjde in the presence of an in- 
TYCTTTETCCCPRCI . ..~~..~... 
TTCTT~A~GAAAGYTTAAG&AAGA~G~C~YCTCTt~T 
Fip.2. (a) 3 ’ -terminal sequence of ~~~~~haiomyoeard~tis 
RNA [14& Arrows show the sequence corresponding to 
the &a 365 fragment which was used as a target for the 
com~~~menta~ addressed rn~if~~at~~~. Guanosine 
residues attacked in the target DNA fragment by the 
oli~~nucIeotide derivative are underlaps, (b) Alkylatin~ 
oiigon~c~eotide derivative. 
complete set of d~x~r~bonucIeoside t~iphosphates 
with formation of the expected products of efonga- 
tion thus demonstrating that the binding site in the 
DNA fragment is unique. The target DNA frag- 
ment representing the sequence of the viral RNA 
and the complementary DNA fragment were modi- 
fied with the oligonucfeotide reagent. The reaction 
was performed under conditions providing com- 
plementary complex formation. Alkylated DNA 
fragments were treated further with piperidine to 
split them at the positions of alkylated nucleotide~ 
and the splitting products were analysed by gel 
dectrophoresis, it was found that sphtting of the 
alkyiated target DNA fragment occurs exclusively 
at positions of 3 gunnosine residues located within 
the sequence compiementary to the oligonucleotide 
reagent (fig.3). In the absence of sahs and buffer, 
modification resulted in a Iow efficient randomr 
alk~la~~on f guanosines in the DNA fragments. 
Fig. 1. Cloning af the Pst 500 DNA fragment at the PstI 
site of Ml3 mp9 bacteriophage RNA. (+ and >) PstL 
and Rsa sites, respectively, in the cloned sequence. 
(--+) 5 ‘-3’orientations of the DNA fragments repre- 
senting the viral RNA sequence. 
-50 
5’ .~,AAAAATlTTGAATTTGATGATGTGAAGGTGT~GT~G~C66A6AT 
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Fig.3. Analysis of the target Rsu 365 DNA fragment 
alkylated with the oligonucleotide derivative. (1) Control 
treatment of the unmodified fragment with piperidine, 
(2) A + G specific splitting of the fragment according to 
[16], (3,4,5 respectively) the fragment modification with 
the oligonucleotide reagent for 15, 60 and 150min at 
37°C and consequent treatment with piperidine (6) DNA 
fragment complementary to the target Rsu 365 DNA 
Ul 
[21 
]31 
141 
[51 
WI 
fragment, alkylation and treatments as in (4). [71 
The results obtained clearly demonstrate se- 
quence-specific complementary addressed modi- 
fication of single-stranded DNA sequence with the 
alkylating oligonucleotide derivative. An unsuc- 
cessful attempt to accomplish sequence-specific 
modification of a DNA fragment with an alkylat- 
ing oligonucleotide derivative was reported in [9]. 
The alkylating group used in [9] was different from 
that used here. Modification of the fragment was 
found to proceed predominantly within a short 
DNA sequence which is, however, remote from the 
target sequence. The result was ascribed to the ef- 
fect of the fragment tertiary structure in which the 
target sequence could be juxtaposed to other se- 
quences. It was unclear whether the effect ob- 
served is unique or if the interference of the poly- 
nucleotide tertiary structure with the specificity of 
the complementary addressed modification is a 
general phenomenon. In the latter case the possi- 
bility of sequence-specific modification of poly- 
nucleotides could be doubtful. The present results 
demonstrate that sequence-specific complementary 
addressed modification with alkylating oligonu- 
cleotide derivates can be achieved in the case of 
rather long nucleic acid fragments, thus providing 
one more tool for site-directed mutagenesis and a 
potential tool for specific damage of preselected 
nucleic acids. 
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